Dr Oliver Zolman
InvestorExecutive in Residence at Brookstreet Equity Partners
About
Dr Oliver Zolman is a medical doctor and researcher focused on longevity medicine, biological ageing, and translational therapeutics, using biomarker-driven, multi-intervention protocols to improve human healthspan. He developed the "82 Organs Framework" for organ-system-level assessment and created "Project Blueprint" for Bryan Johnson, and was recruited for the XPRIZE Healthspan Prize. As Executive in Residence at Brookstreet, he supports the evaluation of longevity-focused investment opportunities and due diligence.
Invests in
Longevity
Colleagues at Brookstreet Equity Partners
Chris Smith
IC | Green Investments at Brookstreet Equity Partners
Christopher Willmott
Board at Brookstreet Equity Partners
Christos Megalou
CEO, Piraeus Bank at Brookstreet Equity Partners
Davinia Smith
Advisory Council at Brookstreet Equity Partners
Dr. Leonid Shapiro, MD
IC | Scale Up Due Diligence at Brookstreet Equity Partners
Gottfried Springer
Investment Manager at Brookstreet Equity Partners
Nancy Papaioannou
Advisory Council at Brookstreet Equity Partners
Natalia Bolou
Partner | Sustainability at Brookstreet Equity Partners
Frequently asked questions
- Who is Dr Oliver Zolman?
- Dr Oliver Zolman is a medical doctor and researcher focused on longevity medicine, biological ageing, and translational therapeutics, using biomarker-driven, multi-intervention protocols to improve human healthspan. He developed the "82 Organs Framework" for organ-system-level assessment and created "Project Blueprint" for Bryan Johnson, and was recruited for the XPRIZE Healthspan Prize. As Executive in Residence at Brookstreet, he supports the evaluation of longevity-focused investment opportunities and due diligence.
- Where does Dr Oliver Zolman work?
- Dr Oliver Zolman is Executive in Residence at Brookstreet Equity Partners.
- What does Dr Oliver Zolman invest in?
- Dr Oliver Zolman invests in Longevity.